Martinrea International Inc. Reports Third Quarter Results and Declares Dividend

Executive Summary

• Martinrea International reported Q3 2025 total sales of C$1.19 billion (‑3.8% YoY) and adjusted EBITDA of C$140.4 million, with Adjusted Operating Income Margin improving to 5.5% (+20 bps).
• Diluted net earnings per share rose to $0.49 (up 158% YoY); Adjusted diluted EPS increased to $0.52 (up 174%).
• The Board declared a quarterly cash dividend of $0.05 per share and disclosed post‑quarter acquisitions (Lyseon North America) and an equity investment in NanoXplore.

Key Details

• Financial Highlights – Q3 2025
• Total sales: C$1,190.8 M (production sales C$1,159.2 M).
• Diluted net earnings per share: $0.49; Adjusted diluted EPS: $0.52.
• Adjusted EBITDA: C$140.4 M (11.8% of sales).
• Adjusted Operating Income Margin: 5.5%, up 20 bps YoY.
• Free Cash Flow (ex‑IFRS 16): C$44.5 M, impacted by delayed receivables from a cybersecurity incident (now resolved).

• Net Debt/Adjusted EBITDA: 1.50×, meeting target.

• Year‑to‑Date (9 months) Highlights

• Sales: C$3,634.6 M (‑5.9% YoY).
• Adjusted EBITDA: C$446.7 M (12.3% of sales).

• Adjusted Net Income: C$115.0 M; Adjusted diluted EPS: $1.58.

• Dividends

• Quarterly cash dividend declared at $0.05 per share, payable to shareholders of record on Dec 31 2025 (payment ≈ Jan 15 2026).

• Acquisitions & Investments

• Acquired Lyseon North America (single‑plant school‑bus parts operation in Tulsa, OK); expected accretive over time.

• Invested $5.6 M in NanoXplore to maintain pro‑rata interest in its C$25.7 M private placement; NanoXplore recently signed a graphene supply agreement with Chevron Phillips.

• Operating Commentary

• CEO Pat D’Eramo highlighted margin improvement, commercial recoveries from EV program shortfalls, and resumption of production at Jaguar Land Rover (expected normal by Q1 2026).

• CFO Peter Cirulis noted restructuring costs of C$2.5 M in Q3 (rightsizing operations in Germany, Mexico, Canada, US) and a larger C$33.1 M over the nine‑month period.

• Guidance

• FY 2025 outlook reaffirmed: total sales $4.8–$5.1 B; Adjusted Operating Income Margin 5.3%–5.8%; Free Cash Flow $125–$175 M.

• Anticipates further margin improvement in FY 2026.

• Balance Sheet Highlights (as of Sep 30 2025)

• Cash & equivalents: C$143 M (down from C$168 M).
• Total assets: C$3,925 M; total equity: C$1,536 M.

• Long‑term debt: C$895 M; current portion of long‑term debt: C$16.1 M.

• Cash Flow Summary (Q3 2025)

• Net cash provided by operating activities: C$107.5 M.
• Net cash used in financing activities: C$(67.4) M (including dividend payments of C$3.6 M and debt repayments).

• Net cash used in investing activities: C$(56.5) M (primarily PP&E purchases).

• Conference Call – Tuesday, Nov 11 2025 at 5:30 p.m. ET; webcast available on the company website.

Notable Quotes

“We are very pleased with our performance in the third quarter… Adjusted Operating Income Margin was higher year over year… We are maintaining our 2025 outlook…” – Pat D’Eramo, CEO
“Free Cash Flow of $44.5 M was impacted by delayed receivables due to a cybersecurity incident at JLR; those have now been collected.” – Peter Cirulis, CFO